September 2010 – Vol 12 – No. 3

State of the art

The diagnostic concept of schizophrenia: its history, evolution, and future prospects
Assen Jablensky, MD

Translational research

Genetics in schizophrenia: where are we and what next?
Arun K. Tiwari, PhD; Clement C. Zai, PhD; Daniel J. Müller, MD; James L. Kennedy, MD

The epidemology of schizophrenia: replacing dogma with knowledge
Simona A. Stilo, MD; Robin M. Murray, DsC

Structural neuroimaging in schizophrenia from methods to insights to treatments
Martha E. Shenton, PhD; Thomas J. Whitford, PhD; Marek Kubicki, MD

Functional magnetic resonance imaging in schizophrenia
Raquel E. Gur, MD; Ruben C. Gur, Phd

Pharmacological aspects

Pharmacologic treatment of schizophrenia
John M. Kane; Christoph U. Correll (USA)

Beyond the dopamine receptor: novel therapeutic targets for treating schizophrenia
Joseph T. Coyle, MD; Darrick Balu, PhD; Michael Benneyworth, PhD; Alo Basu, PhD; Alexander Roseman, BS

Clinical research

The assessment of neuropsychological functioning in schizophrenia
Abraham (Avi) Reichenberg, PhD

Remission in schizophrenia: validity, frequency, predictors, and patients’ perspective 5 years later
Martin Lambert, MD; Anne Karow, MD; Stefan Leucht, MD; Benno G. Schimmelmann, MD; Dieter Naber, MD

The lifetime trajectory of schizophrenia and the concept of neurodevelopment
Nancy C. Andreasen, MD

Brief report

Cognitive training in schizophrenia: a neuroscience-based approach
Alexander Genevsky, MA; Coleman T. Garrett, BS; Phillip P. Alexander, BS; Sophia Vinogradov, MD